Picture: Getty Images
Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
It’s been a great few weeks to be a share market investor and the healthcare sector has been no exception.
Seventy-seven of the small-cap companies in the sector have gained ground over the last month (October 25 to November 25), four have been flat and just 46 retreated.
| Code | Company | Price | MktCap | Month return | Six month return | Week return | %Yr |
|---|---|---|---|---|---|---|---|
| CAN | Cann Group Ltd | 0.56 | $ 136,304,740.89 | 45 | -45 | 78 | -24 |
| APH | AP Hemp Ltd | 0.27 | $ 16,825,540.80 | 46 | 125 | 50 | 26 |
| ONE | Oneview Healthcare | 0.058 | $ 11,991,921.81 | 29 | 22 | 45 | -60 |
| IPD | Impedimed Limited | 0.1425 | $ 145,340,469.45 | 76 | 134 | 36 | -18 |
| MX1 | Micro-X Limited | 0.345 | $ 122,176,196.02 | 64 | 156 | 35 | 50 |
| ADR | Adherium Ltd | 0.033 | $ 21,034,555.86 | 38 | 43 | 32 | -20 |
| RAC | Race Oncology Ltd | 1.81 | $ 237,093,918.75 | 72 | 466 | 29 | 1193 |
| IHL | Incannex Healthcare | 0.145 | $ 136,854,969.53 | 75 | 174 | 26 | 113 |
| IMU | Imugene Limited | 0.125 | $ 561,062,280.00 | 108 | 268 | 25 | 119 |
| ICR | Intelicare Holdings | 0.28 | $ 9,893,840.19 | -5 | 40 | 24 | 0 |
| THC | THC Global Grp Ltd | 0.255 | $ 42,829,667.76 | 2 | -32 | 21 | -35 |
| FFC | Farmaforce Ltd | 0.085 | $ 10,945,533.30 | 21 | 6 | 21 | -11 |
| PGC | Paragon Care Limited | 0.26 | $ 89,539,602.38 | 33 | 53 | 21 | -41 |
| ALT | Analytica Limited | 0.003 | $ 7,039,224.66 | 0 | 50 | 20 | 0 |
| TLX | Telix Pharmaceutical | 3.12 | $ 868,902,369.30 | 85 | 114 | 20 | 70 |
| JHC | Japara Healthcare Lt | 0.825 | $ 220,479,045.60 | 106 | 54 | 20 | -26 |
| BOT | Botanix Pharma Ltd | 0.125 | $ 126,450,745.72 | 25 | 178 | 19 | 19 |
| KZA | Kazia Therapeutics | 1.39 | $ 172,847,781.68 | 74 | 263 | 17 | 230 |
| OCC | Orthocell Limited | 0.435 | $ 80,382,326.30 | 21 | 23 | 16 | -24 |
| ALC | Alcidion Group Ltd | 0.22 | $ 203,092,280.66 | 76 | 47 | 16 | 5 |
| OVN | Oventus Medical Ltd | 0.24 | $ 37,191,668.00 | 4 | -6 | 14 | -55 |
| VTI | Vision Tech, Inc | 0.033 | $ 33,786,669.01 | -15 | 94 | 14 | -53 |
| MEM | Memphasys Ltd | 0.125 | $ 90,572,865.60 | 9 | 89 | 14 | 108 |
| UBI | Universal Biosensors | 0.43 | $ 76,312,904.10 | 34 | 126 | 12 | 132 |
| ZLD | Zelira Therapeutics | 0.08 | $ 93,640,514.31 | 0 | 74 | 11 | 16 |
| MDC | Medlab Clinical Ltd | 0.205 | $ 54,536,755.85 | 3 | -5 | 11 | -47 |
| CTE | Cryosite Limited | 0.31 | $ 14,057,868.90 | 27 | 265 | 11 | 560 |
| CMP | Compumedics Limited | 0.555 | $ 97,439,621.40 | 23 | 10 | 9 | -35 |
| ACR | Acrux Limited | 0.185 | $ 32,062,006.57 | 3 | 37 | 9 | 3 |
| PNV | Polynovo Limited | 3.1 | $ 2,042,762,055.96 | 26 | 18 | 9 | 62 |
| RHY | Rhythm Biosciences | 0.51 | $ 90,673,114.95 | 143 | 495 | 9 | 276 |
| BNO | Bionomics Limited | 0.13 | $ 91,905,943.75 | 4 | 187 | 8 | 38 |
| AVE | Avecho Biotech Ltd | 0.013 | $ 20,766,946.46 | -7 | 63 | 8 | 225 |
| NYR | Nyrada Inc. | 0.31 | $ 15,214,573.80 | -5 | 31 | 8 | 0 |
| AC8 | Auscann Grp Hlgs Ltd | 0.145 | $ 42,801,393.20 | 4 | -19 | 7 | -34 |
| SUD | Suda Pharmaceuticals | 0.044 | $ 12,273,436.08 | 7 | 27 | 7 | -26 |
| 4DX | 4Dmedical Limited | 2.27 | $ 393,302,490.66 | 8 | 0 | 7 | 0 |
| SVA | Simavita Ltd | 0.016 | $ 19,615,720.47 | 7 | -11 | 7 | 220 |
| OPT | Opthea Limited | 2.32 | $ 780,004,230.39 | -1 | -17 | 6 | -14 |
| SCU | Stemcell United Ltd | 0.017 | $ 10,745,733.82 | 6 | 70 | 6 | 31 |
| RHT | Resonance Health | 0.175 | $ 77,756,688.28 | 9 | 3 | 6 | 9 |
| OIL | Optiscan Imaging | 0.105 | $ 62,656,681.50 | -5 | 144 | 6 | 169 |
| IBX | Imagion Biosys Ltd | 0.1325 | $ 136,758,154.95 | 72 | 430 | 6 | 575 |
| RNO | Rhinomed Ltd | 0.185 | $ 45,685,643.76 | 6 | 161 | 6 | -18 |
| RAP | Resapp Health Ltd | 0.095 | $ 67,472,634.52 | -17 | -46 | 6 | -67 |
| EXL | Elixinol Global | 0.19 | $ 47,004,034.16 | 27 | -14 | 6 | -82 |
| 1ST | 1St Group Ltd | 0.04 | $ 16,984,676.12 | 21 | 25 | 5 | -51 |
| MDR | Medadvisor Limited | 0.405 | $ 132,731,893.32 | 1 | -21 | 5 | 25 |
| OSL | Oncosil Medical | 0.1725 | $ 138,511,498.62 | 28 | 64 | 5 | 1 |
| IVX | Invion Ltd | 0.0115 | $ 66,444,507.54 | 5 | 44 | 5 | 15 |
| AGH | Althea Group | 0.49 | $ 112,765,153.73 | 2 | 27 | 4 | 14 |
| MMJ | MMJ Group Hlds Ltd | 0.125 | $ 28,744,248.13 | 14 | -7 | 4 | -32 |
| IMC | Immuron Limited | 0.26 | $ 61,246,126.62 | -4 | 229 | 4 | 100 |
| CDX | Cardiex Limited | 0.052 | $ 45,235,877.00 | 8 | 117 | 4 | 93 |
| MVF | Monash IVF Group Ltd | 0.79 | $ 305,863,349.40 | 37 | 44 | 4 | -18 |
| CYC | Cyclopharm Limited | 2.2 | $ 176,603,801.00 | 9 | 59 | 4 | 83 |
| TD1 | Tali Digital Limited | 0.03 | $ 22,479,156.54 | 3 | 7 | 3 | -57 |
| EYE | Nova EYE Medical Ltd | 0.34 | $ 48,824,386.92 | 5 | 34 | 3 | 13 |
| PTX | Prescient Ltd | 0.069 | $ 43,557,604.68 | 13 | 53 | 3 | -16 |
| JHL | Jayex Healthcare Ltd | 0.038 | $ 7,047,705.84 | -14 | 52 | 3 | 0 |
| IDT | IDT Australia Ltd | 0.19 | $ 45,281,686.16 | 23 | 23 | 3 | 27 |
| OSX | Osteopore Limited | 0.6 | $ 46,822,680.00 | 11 | 20 | 3 | -26 |
| LSH | Lifespot Health Ltd | 0.09 | $ 12,803,481.84 | 50 | 200 | 2 | 157 |
| ONT | 1300 Smiles Limited | 6.6 | $ 153,909,496.00 | -3 | 27 | 2 | 6 |
| PXS | Pharmaxis Ltd | 0.097 | $ 38,494,968.76 | 10 | 8 | 2 | -57 |
| NC6 | Nanollose Limited | 0.06 | $ 7,300,499.44 | -19 | 88 | 2 | -5 |
| VBS | Vectus Biosystems | 1.01 | $ 22,123,331.40 | 3 | 48 | 2 | 76 |
| PBP | Probiotec Limited | 2.15 | $ 160,774,570.50 | 24 | 15 | 1 | 10 |
| VHT | Volpara Health Tech | 1.38 | $ 361,179,476.64 | -8 | 1 | 1 | -23 |
| RCE | Recce Pharmaceutical | 1.11 | $ 197,939,539.50 | 5 | 94 | 0 | 325 |
| ARX | Aroa Biosurgery | 1.3 | $ 387,096,685.50 | -12 | 0 | 0 | 0 |
| PSQ | Pacific Smiles Grp | 1.96 | $ 300,890,478.00 | 1 | 51 | 0 | 7 |
| S66 | Star Combo | 0.345 | $ 47,437,810.35 | 0 | -19 | 0 | -28 |
| PAA | Pharmaust Limited | 0.11 | $ 34,785,291.20 | -15 | 12 | 0 | -4 |
| NXS | Next Science Limited | 1.16 | $ 139,556,642.30 | -3 | -24 | 0 | -54 |
| NTI | Neurotech Intl | 0.029 | $ 14,519,184.72 | 12 | 383 | 0 | 93 |
| MXC | Mgc Pharmaceuticals | 0.022 | $ 34,725,805.61 | -8 | -12 | 0 | -35 |
| MEB | Medibio Limited | 0.013 | $ 17,519,613.40 | 18 | 123 | 0 | 67 |
| LCT | Living Cell Tech. | 0.014 | $ 8,571,614.72 | -7 | 8 | 0 | -26 |
| GTG | Genetic Technologies | 0.007 | $ 66,093,813.94 | -18 | 0 | 0 | 75 |
| GSS | Genetic Signatures | 1.75 | $ 252,888,300.42 | -12 | -12 | 0 | 55 |
| CPH | Creso Pharma Ltd | 0.032 | $ 21,340,970.93 | 10 | -53 | 0 | -84 |
| CAJ | Capitol Health | 0.28 | $ 281,902,434.00 | 10 | 37 | 0 | 19 |
| BD1 | Bard1 Life Sciences | 0.025 | $ 59,863,259.60 | -4 | -7 | 0 | -26 |
| AMT | Allegra Orthopaedics | 0.15 | $ 16,713,472.48 | -9 | 30 | 0 | -38 |
| AHK | Ark Mines Limited | 0.034 | $ 1,778,919.95 | 0 | 0 | 0 | 0 |
| ACW | Actinogen Medical | 0.023 | $ 33,368,104.89 | 5 | 24 | 0 | -53 |
| 1AD | Adalta Limited | 0.115 | $ 28,195,223.10 | -18 | 64 | 0 | -3 |
| ZNO | Zoono Group Ltd | 1.37 | $ 219,241,027.38 | -8 | -27 | 0 | 349 |
| CYP | Cynata Therapeutics | 0.84 | $ 100,726,643.44 | 1 | 24 | -1 | -29 |
| ANP | Antisense Therapeut. | 0.099 | $ 56,198,817.10 | -22 | 48 | -1 | 9 |
| ICS | ICSGlobal Limited | 1.87 | $ 19,574,675.34 | 13 | 7 | -1 | 10 |
| SDI | SDI Limited | 0.81 | $ 93,903,768.70 | -3 | 11 | -1 | -7 |
| AT1 | Atomo Diagnostics | 0.325 | $ 132,385,609.53 | 3 | -10 | -2 | 0 |
| PAL | Palla Pharma Ltd | 0.81 | $ 99,498,901.83 | 13 | 25 | -2 | -6 |
| DXB | Dimerix Ltd | 0.255 | $ 50,457,945.74 | -7 | 0 | -2 | 132 |
| M7T | Mach7 Tech Limited | 1.2 | $ 288,580,595.10 | 23 | 79 | -2 | 72 |
| PAR | Paradigm Bio. | 2.99 | $ 677,413,644.00 | 6 | 21 | -3 | -15 |
| RSH | Respiri Limited | 0.17 | $ 118,691,065.35 | -13 | 146 | -3 | 93 |
| VLS | Vita Life Sciences.. | 0.845 | $ 47,322,285.50 | -3 | 56 | -3 | 39 |
| CGS | Cogstate Ltd | 1.01 | $ 172,690,405.97 | 27 | 221 | -3 | 153 |
| DVL | Dorsavi Ltd | 0.031 | $ 9,556,404.80 | -21 | 54 | -3 | 8 |
| MVP | Medical Developments | 6.14 | $ 398,334,590.37 | 12 | -21 | -3 | -15 |
| CP1 | Cannpal Animal | 0.14 | $ 12,571,875.00 | 27 | 51 | -3 | 17 |
| NEU | Neuren Pharmaceut. | 1.3 | $ 157,013,107.96 | 18 | -24 | -4 | -46 |
| LBT | LBT Innovations | 0.125 | $ 36,814,719.11 | 4 | -17 | -4 | -32 |
| BWX | BWX Limited | 4.05 | $ 567,944,071.86 | -5 | 10 | -4 | -9 |
| PAB | Patrys Limited | 0.021 | $ 32,783,544.19 | -12 | 51 | -5 | -12 |
| CDY | Cellmid Limited | 0.1 | $ 12,524,686.60 | -5 | -46 | -5 | -57 |
| SOM | SomnoMed Limited | 2.13 | $ 171,311,782.05 | -7 | 111 | -5 | -13 |
| PCK | Painchek Ltd | 0.086 | $ 96,905,212.71 | -11 | -46 | -5 | -68 |
| NSB | Neuroscientific | 0.335 | $ 27,452,380.10 | 5 | 81 | -6 | 37 |
| OSP | Osprey Med Inc | 0.0225 | $ 35,713,633.16 | -6 | 125 | -6 | -44 |
| PIQ | Proteomics Int Lab | 0.51 | $ 55,075,584.38 | -14 | 55 | -6 | 62 |
| NOX | Noxopharm Limited | 0.63 | $ 137,960,559.30 | 25 | 180 | -7 | 110 |
| ADO | Anteotech Ltd | 0.08 | $ 139,501,538.48 | -27 | 220 | -7 | 289 |
| HCT | Holista CollTech Ltd | 0.069 | $ 18,723,737.92 | -28 | -52 | -8 | -9 |
| RGS | Regeneus Ltd | 0.11 | $ 34,532,703.82 | -23 | 47 | -8 | 12 |
| PYC | PYC Therapeutics | 0.16 | $ 491,493,545.97 | -9 | 101 | -9 | 160 |
| BIT | Biotron Limited | 0.082 | $ 58,260,415.18 | -9 | -15 | -10 | 32 |
| AZV | Azure Healthcare Ltd | 0.09 | $ 25,577,005.59 | -6 | 36 | -10 | 26 |
| IMM | Immutep Ltd | 0.265 | $ 166,343,078.52 | 2 | 71 | -10 | 2 |
| BPH | BPH Energy Ltd | 0.033 | $ 16,461,350.97 | -35 | 376 | -11 | 154 |
| ATX | Amplia Therapeutics | 0.215 | $ 23,637,020.00 | -17 | 66 | -12 | 191 |
| GLH | Global Health Ltd | 0.46 | $ 20,207,193.60 | 35 | 229 | -14 | 241 |
| ATH | Alterity Therap Ltd | 0.033 | $ 75,145,149.19 | -13 | 65 | -20 | 32 |
| BXN | Bioxyne Ltd | 0.012 | $ 7,681,744.78 | -20 | 0 | -20 | -25 |
The biggest gainer has been Rhythm Biosciences (ASX:RHY), whose shares were trading at 51c yesterday, up from 143 per cent from a month ago and up more than sixfold from early August.
The company early this month completed a prototype of its ColoSTAT rapid blood test to screen for colorectal cancer, a test the company hopes will replace the current faecal tests.
Imugene (ASX:IMU) has been the second-biggest gainer, with its shares more than doubling to 12.5c after the Sydney biotech received US Food and Drug Administration approval to begin a phase 1 clinical trial of its checkpoint immunotherapy drug candidate PD1-Vaxx in lung cancer patients.
Rounding out the top three has been aged care operator Japara Healthcare (ASX:JHC) whose shares have also doubled to 82.5c on optimism over vaccines ending the coronavirus crisis.
An honourable mention goes to nuclear medicine company Telix Pharmaceuticals (ASX:TLX), whose shares are up a very respectable 85 per cent in the 31-day span on a licensing deal in China and progress on its prostate cancer imaging agent.
On the flip side, BPH Energy (ASX:BPH) shares have run out of puff in the past month, for no reason that was immediately obvious looking at the company’s announcements.
BPH shares were trading at 3.3c on Wednesday, down 35 per cent from the same time in October, although up 376 per cent in the past six months.
Health & Biotech
Health & Biotech
News
Get the latest Stockhead news delivered free to your inbox.
